Search clinical trials for: Attack

Total 840 results

Athersys, Inc
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction (MI-NSTEMI)

Heart Attack | NSTEMI

United States
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Shire

Completed

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Hereditary Angioedema

United States
Shire

Completed

A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Hereditary Angioedema

United States, Australia, Israel, Canada, Hungary, Romania, Russian Federation, South Africa, Ukraine
Eli Lilly and Company

Completed

A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine (MONONOFU)

Migraine

Japan
Wake Forest University Health Sciences
Duke University; University of North Carolina, Chapel Hill; East Carolina University

Completed

Comprehensive Post-Acute Stroke Services (COMPASS)

Stroke | Transient Ischemic Attack

United States
Shire

Completed

Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)

Hereditary Angioedema (HAE)

United States
Shire

Completed

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE) (FAST2)

Hereditary Angioedema

Italy
Shire

Completed

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Angioedema

United States
Shire

Completed

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Hereditary Angioedema (HAE)

United States, Jordan, Canada
Shire

Completed

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Hereditary Angioedema (HAE)

United States, Canada, Jordan
Shire

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 3)

Hereditary Angioedema

United States
Shire

Completed

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Hereditary Angioedema (HAE)

United States
Shire

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 2)

Hereditary Angioedema

United States
Shire

Completed

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Hereditary Angioedema (HAE)

United States, United Kingdom, Germany, Canada, Italy, Jordan, Puerto Rico
Shire

Completed

Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Hereditary Angioedema (HAE)

Spain, Israel, United States, Hungary, Germany, Canada, Romania
Shire

Completed

CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12

Hereditary Angioedema (HAE)

United States, Germany, Hungary
Shire

Completed

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Hereditary Angioedema (HAE)

United States, Germany, Spain, Sweden
Shire

Completed

Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema

Hereditary Angioedema (HAE)

Israel, Germany, Mexico, United States, Romania
Shire

Completed

A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants

Hereditary Angioedema (HAE)

Japan
Shire
Dyax Corp.

Completed

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Hereditary Angioedema (HAE)

United States, Canada, Germany, Italy, Jordan, Puerto Rico, United Kingdom
Shire

Completed

Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)

Hereditary Angioedema (HAE)

Japan
University of Leicester

Terminated

Cerebral Haemodynamics in Transient Ischaemic Attack

Transient Ischemic Attack

United Kingdom
University of Miami
University of California, Los Angeles; Northwestern University; National Institute... and other collaborators

Completed

Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD)

Intracranial Vascular Disorders

United States
University of Texas at Austin

Completed

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine (DCS/PSRT)

Panic Attack | Nicotine Addiction

United States
Shire

Withdrawn

Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Hereditary Angioedema (HAE)
John Barnard
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Molecular Determinants of Coronaruy Artery Disease (GeneQuest)

Myocardial Infarction | Coronary Artery Disease | Arteriovenous Malformations

United States
University of Minnesota

Completed

Smoking Cessation in Menthol Flavored Cigarette Smokers

Tobacco Use Disorder

United States
Olivier CHASSANY
Beaujon Hospital; Bichat Hospital; EA 7334, Patient-Centered Outcomes Research

Completed

Asthma Attack in the Emergency Department : Reasons Of This Attendance (AERO)

Emergency Medicine | Asthma Attack

France
Queen Mary University of London

Completed

BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction (BAMI)

Myocardial Infarction | Death

Spain, Germany, Switzerland, Italy, Finland, Czechia, Belgium, Denmark, Netherlands, United Kingdom
Janssen Research & Development, LLC

Completed

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Dry Age-related Macular Degeneration

United States
BioCryst Pharmaceuticals

Completed

Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

Hereditary Angioedema (HAE)

Austria, Denmark, France, Germany, Hungary, Israel, Italy, North Macedonia, Poland, Romania, Switzerland, United Kingdom
BioCryst Pharmaceuticals

Completed

Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema (APeX-1)

Hereditary Angioedema (HAE)

Canada, United Kingdom, Germany, Spain, Australia, Hungary, Italy, Austria, North Macedonia, Denmark, Switzerland
Dr. Lutfi Kirdar Kartal Training and Research Hospital

Completed

Comparison of Great Occipital Nerve and Supraorbital Nerve Blockade Methods at Treatment of Acute Migraine Attack in the Emergency Department

Migraine Disorders

Turkey
Quality Living, Inc.

Completed

Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention

Migraine Disorders | Aphasia

United States
Mayo Clinic

Completed

CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function (BELIEVE III)

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

United States
Nordsjaellands Hospital
Rigshospitalet, Denmark; Metropolitan University College

Completed

Lifestyle Counselling as Secondary Prevention in Patients With Minor Stroke and Transient Ischemic Attack

Transient Ischemic Attack | Stroke, Ischemic | Stroke Hemorrhagic

Denmark
Ministry of Science and Technology of the People´s...
The Affiliated Hospital of Qingdao University; Shenzhen Second People's Hospital and other collaborators

Unknown

An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases (PLATFORM-CVD)

Stroke | Transient Ischemic Attack | Cerebral Infarction | Subarachnoid Hemorrhage | Cerebral Hemorrhage | Cerebrovascular Diseases

China
Biohit Oyj
The Finnish Funding Agency for Technology and Innovation (TEKES)

Completed

The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients

Migraine

Estonia, Finland
Hospital Universitario de Canarias

Unknown

Clinical Trial in Patients Who Have Suffered a Heart Attack and Who Have Undergone Catheterization Treated With Levosimendan (LEVOCEST)

ST Elevation Myocardial Infarction

Spain
AdvanceCor GmbH

Completed

Revacept in Symptomatic Carotid Stenosis (RevaceptCS02)

Stroke | Atherosclerosis | Carotid Stenosis | TIA | Transient-ischaemic Attack | Amaurosis Fugax

Germany, United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks

Panic Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

Migraine With or Without Aura
Bispebjerg Hospital

Completed

Acute MRI in Transient Ischemic Attack

Ischemic Attack, Transient

Denmark
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain

Pain | Neuralgia | Spinal Cord Diseases | Spinal Cord Injuries

Japan
Manchester University NHS Foundation Trust

Withdrawn

T-MACS Decision Aid: a Randomized, Controlled Point of Care Trial

Chest Pain | Acute Coronary Syndrome | Heart Attack

United Kingdom
Saglik Bilimleri Universitesi

Completed

Does Positioning Effects on Early Postoperative Cognitive Dysfunction in Laparoscopic Oncological Surgery

Ischemic Attack, Transient

Turkey
Universidade do Porto
University of Lisbon; Instituto Politécnico de Leiria

Unknown

Physical/Self-perceived Performance and 3D Shoulder Kinematics of Volleyball Attackers With/Without Shoulder Complaints and Scapular Dyskinesis

Shoulder Pain

Portugal
Novartis Pharmaceuticals

Completed

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Asthma

United States
Novartis Pharmaceuticals

Completed

Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma (QVM149)

Asthma

Germany, Netherlands, United Kingdom

Search clinical trials for: Attack

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations